MediWound Announces Positive Initial DataMDWD: MediWound Ltd.
2022-07-11 07:00:00
MediWound Announces Positive Initial Data from its U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.16 USD
−6.72 M USD
18.69 M USD
6.36 M
About MediWound Ltd.
Sector
CEO
Ofer Gonen
Headquarters
Yavne
Website
Founded
2000
ISIN
IL0011316309
FIGI
BBG005ZPKRQ4
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.
MediWound Announces Positive ResultsMDWD: MediWound Ltd.
2022-07-07 07:00:00
MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers
MediWound Announces Positive Results from Its U.S. Phase 2 TrialMDWD: MediWound Ltd.
2022-05-12 07:00:00
MediWound Announces Positive Results from Its U.S. Phase 2 Trial of EscharEx for Debridement of Chronic Wounds
$MDWD is gonna fall todayPupm&Dump trading strategy idea.
$MDWD is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $5,52;
stop-loss — $5,97;
take-profit — $4,62.
Do not view th
$MDWDEntry price : 5.91
Fundamentals :
- Sector: Medical Biotech
- EPS % Chg (Last Qtr): 33%
- EPS % Chg (Previous Qtr): -123%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 29%
- Sales % Chg (Previous Qtr): -81%
- 3-Year Sales Growth Rate: 183%
- Annua
MDWD LONG - TRADING IDEAMDWD micro cap coming out of a nice base - phase 3 trial results and earnings on the horizon as potential catalysts here
No Wound, Please!What I see...
+ Inside Hammer, NR7, and NR3 combo!!
+ ... with 10ma support
+ High vol.
+ MACD is flat but bullish
+ RSI at 56
+ Bollinger is narrow
+ Low price stock
- 1st Resistance at 2.18; 2nd at 2.40
- 10ma is not piercing through the body
- Very low vol. stock
What I setup...
+ Long entry ab
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MDWD is 16.48 USD — it has decreased by −1.67% in the past 24 hours. Watch MediWound Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MediWound Ltd. stocks are traded under the ticker MDWD.
MDWD stock has risen by 0.49% compared to the previous week, the month change is a −2.94% fall, over the last year MediWound Ltd. has showed a 100.49% increase.
We've gathered analysts' opinions on MediWound Ltd. future price: according to them, MDWD price has a max estimate of 36.00 USD and a min estimate of 25.00 USD. Watch MDWD chart and read a more detailed MediWound Ltd. stock forecast: see what analysts think of MediWound Ltd. and suggest that you do with its stocks.
MDWD reached its all-time high on Mar 21, 2014 with the price of 135.13 USD, and its all-time low was 7.10 USD and was reached on Sep 8, 2023. View more price dynamics on MDWD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MDWD stock is 2.50% volatile and has beta coefficient of 0.97. Track MediWound Ltd. stock price on the chart and check out the list of the most volatile stocks — is MediWound Ltd. there?
Today MediWound Ltd. has the market capitalization of 177.76 M, it has increased by 4.75% over the last week.
Yes, you can track MediWound Ltd. financials in yearly and quarterly reports right on TradingView.
MediWound Ltd. is going to release the next earnings report on Nov 26, 2024. Keep track of upcoming events with our Earnings Calendar.
MDWD earnings for the last quarter are −0.68 USD per share, whereas the estimation was −0.42 USD resulting in a −61.90% surprise. The estimated earnings for the next quarter are −0.48 USD per share. See more details about MediWound Ltd. earnings.
MediWound Ltd. revenue for the last quarter amounts to 5.06 M USD, despite the estimated figure of 5.05 M USD. In the next quarter, revenue is expected to reach 6.00 M USD.
MDWD net income for the last quarter is −6.30 M USD, while the quarter before that showed −9.73 M USD of net income which accounts for 35.19% change. Track more MediWound Ltd. financial stats to get the full picture.
No, MDWD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 100.00 employees. See our rating of the largest employees — is MediWound Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MediWound Ltd. EBITDA is −13.94 M USD, and current EBITDA margin is −75.98%. See more stats in MediWound Ltd. financial statements.
Like other stocks, MDWD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MediWound Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MediWound Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MediWound Ltd. stock shows the neutral signal. See more of MediWound Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.